©2018 UpToDate
Medications used to treat lower urinary symptoms attributed to benign prostatic hyperplasia
Drug class
Medication
Alpha-1 blockers (ABs)
Silodosin (Rapaflo)
Terazosin (Hytrin)
Alfuzosin (Uroxatral)
Doxazosin (Cardura)
Tamsulosin (Flomax)
5-alpha-reductase inhibitors (5-ARIs)
Finasteride (Proscar)
Dutasteride (Avodart)
Anticholinergic agents
Oxybutynin (Oxytrol)
Fesoterodine (Toviaz)
Darifenacin (Enablex)
Tolterodine (Detrol, Detrol LA)
Solifenacin (VESIcare)
Trospium (Sanctura)
Beta-3 adrenergic agonist
Mirabegron (Myrbetriq)
Phosphodiesterase type 5 (PDE-5) inhibitors
Tadalafil (Cialis)
Sildenafil (Viagra)
Avanafil (Stendra)
Vardenafil (Staxyn, Levitra)
Adapted from: Brasure M, MacDonald R, Dahm P, et al. Newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: A review. Comparative Effectiveness Review No. 178, AHRQ Publication No. 16-EHC024-EF, Agency for Healthcare Research and Quality, Rockville, MD 2016.
Graphic 110853 Version 2.0
